Metadata
- Name
- Oral GW766944 (Oral CCR3 Antagonist)
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT01160224
- Description
- GW766994 is a selective, competitive antagonist of the human CC chemokine receptor-3 (CCR3).
It is proposed that the inhibition of the CCR3 receptor may provide a treatment for airway
inflammation such as in asthma. This will be a double-blind, placebo controlled, parallel
group study being conducted to evaluate the effects of GW766994 in subjects with
mild-moderate asthma who have high sputum eosinophilia. The primary objective is to compare
the effects of GW766994 to placebo on sputum eosinophils. - Data or Study Types
- clinical trial
- Keywords
- Asthma, GW766944, CCR3 receptor antagonists
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2010
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT01160224
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT01160224